Evidence map›Paper›PMID 36788969›Full record

ReviewRheumatology and immunology research2022

Corona Virus Disease-19 Vaccine-associated Autoimmune Disorders.

Marriam Hussain Awan, Saba Samreen, Babur Salim, Haris Gul, Shahida Perveen, Amjad Nasim

Open access · diamondAbstract readReview
In one paragraph

Review in Rheumatology and immunology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. COVID-19 vaccine-associated autoimmune disorders: Comments.Rheumatology and immunology research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Marriam Hussain AwanPostgraduate Resident in Rheumatology, Fauji Foundation Hospital, Rawalpindi, Pakistan.
Saba SamreenPostgraduate Resident in Rheumatology, Fauji Foundation Hospital, Rawalpindi, Pakistan.
Babur SalimPostgraduate Resident in Rheumatology, Fauji Foundation Hospital, Rawalpindi, Pakistan.
Haris GulPostgraduate Resident in Rheumatology, Fauji Foundation Hospital, Rawalpindi, Pakistan.
Shahida PerveenPostgraduate Resident in Rheumatology, Fauji Foundation Hospital, Rawalpindi, Pakistan.
Amjad NasimPostgraduate Resident in Rheumatology, Fauji Foundation Hospital, Rawalpindi, Pakistan.
Foundation University Medical College · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease is a highly infectious viral disease caused by severe acute respiratory syndrome virus (SARS nCoV2). It was declared a pandemic within a few months of identification of its index case. The spread of COVID-19 across the globe was rampant, overwhelming healthcare systems and crippling global economies. Since the world was caught off guard by the pandemic, vaccine programs had to be rolled out in emergency to curb its spread. Ten vaccines have been granted Emergency Use Authorization thus far. Much of the side effects we know today are post-marketing adverse effects. Most of them are mild like myalgia and injection-site reactions, but a few of them such as post-vaccination autoimmune diseases have alerted the medical community. These include vaccine-induced thrombotic thrombocytopenia, autoimmune hepatitis, myocarditis, and Graves' disease. We attempt to summarize the diverse autoimmune phenomena reported after COVID-19 vaccination, with an aim to sensitize the medical community so that they can be better equipped in management when confronted with these diseases. This review by no means refutes the potential benefit of COVID-19 vaccination which has consolidated its place in preventing infections and substantially reducing severity and mortality.

Indexed as

autoimmune phenomenonCOVID vaccinesSARS CoV2 vaccinationvaccine-induced autoimmunity

Identifiers

PMID36788969
PMCPMC9895874
OpenAlexW4306955489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.